Hypertrophic cardiomyopathy - sports-related aspects of diagnosis, therapy, and sports eligibility

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Hypertrophe Kardiomyopathie - sportbezogene Aspekte der Diagnose, Therapie und Sporteignung
Autor:Hipp, A.A.; Heitkamp, Hans-Christian; Röcker, K.; Dickhuth, H.H.
Erschienen in:International journal of sports medicine
Veröffentlicht:25 (2004), 1, S., Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource Elektronische Ressource (online)
Sprache:Englisch
ISSN:0172-4622, 1439-3964
DOI:10.1055/s-2003-45227
Schlagworte:
Online Zugang:
Erfassungsnummer:PU200403000950
Quelle:BISp

Abstract des Autors

Hypertrophic cardiomyopathy (HCM) is one of the primary causes of sudden cardiac death in athletes < 35 years of age. The highest risk of sudden cardiac death is associated with syncope, early age, extreme ventricular hypertrophy, ventricular tachycardia, and a family history of sudden death. The relative risk in competitive sports is unknown. Usually, sports eligibility is rejected. However, some athletes with HCM tolerate extreme athletic lifestyles without complications. Sports-related aspects of diagnosis, therapy, and sports eligibility are presented, and discussed. Two case reports are presented: a 20-year-old professional soccer player and a 66-year-old long-distance runner. Athletes with HCM should not participate in most competitive sports with the possible exception of those of low dynamic and low static intensity. Participation in low to moderate athletic activities may be allowed in selected patients without risk factors and > 35 years of age. Verf.-Referat